To this end, we assessed DNA damage, through scoring of γ-H2AX foci, and performed whole genome analysis followed by qRT-PCR validation (Fig. 7) on whole blood samples collected from prostate cancer patients undergoing IMRT. Here, H2AX is linked to prostate carcinoma.